1. Centers for Disease Control and Prevention. (2004). Enhanced enforcement of laws to prevent alcohol sales to underage persons—New Hampshire, 1999–2004. MMWR: Morbidity and Mortality Weekly Report, 53, 452–454. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5321a2.htm
2. Corso, P. S. (n.d.). Outcomes Quantified in Dollars: Part IV. Benefit-cost analysis. Centers for Disease Control and Prevention, Division for Heart Disease and Stroke Prevention. Retrieved from https://www.cdc.gov/dhdsp/programs/spha/economic_evaluation/docs/podcast_iv.pdf
3. Crowley, D. M., Dodge, K. A., Barnett, W. S., Corso, P., Duffy, S., Graham, P., et al. (2018). Standards of evidence for conducting and reporting economic evaluations in prevention science. Prevention Science, 19, 366–390. https://doi.org/10.1007/s11121-017-0858-1
4. Crowley, D. M., Hill, L. G., Kuklinski, M. R., et al. (2014). Research priorities for economic analyses of prevention: Current issues and future directions. Prevention Science, 15, 789–798. https://doi.org/10.1007/s11121-013-0429-z
5. Crowley, D. M., Jones, D. E., Coffman, D. L., & Greenberg, M. T. (2014). Can we build an efficient response to the prescription drug abuse epidemic? Assessing the cost effectiveness of universal prevention in the PROSPER trial. Preventive Medicine, 62, 71–77. https://doi.org/10.1016/j.ypmed.2014.01.029